These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32634856)

  • 21. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T; Marquart JA; Marx PF; Meijers JC
    J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
    Stasko J; Hudecek J; Kubisz P
    Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation.
    Incampo F; Carrieri C; Semeraro N; Colucci M
    Thromb Res; 2014 Nov; 134(5):1110-6. PubMed ID: 25193406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin.
    Mosnier LO; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Jan; 85(1):5-11. PubMed ID: 11204587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells.
    Wu C; Kim PY; Swystun LL; Liaw PC; Weitz JI
    J Thromb Haemost; 2016 Feb; 14(2):366-74. PubMed ID: 26663133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation.
    Okada M; Tominaga N; Honda G; Nishioka J; Akita N; Hayashi T; Suzuki K; Moriuchi H
    Blood Adv; 2020 Jun; 4(12):2631-2639. PubMed ID: 32556284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction.
    Toh CH
    Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S69-71. PubMed ID: 14567541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.
    Stanne TM; Olsson M; Lorentzen E; Pedersen A; Gummesson A; Gils A; Jood K; Engström G; Melander O; Declerck PJ; Jern C
    Thromb Haemost; 2018 Feb; 118(2):298-308. PubMed ID: 29378355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex.
    Bajzar L; Morser J; Nesheim M
    J Biol Chem; 1996 Jul; 271(28):16603-8. PubMed ID: 8663147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis.
    Mook-Kanamori BB; Valls Serón M; Geldhoff M; Havik SR; van der Ende A; Baas F; van der Poll T; Meijers JC; P Morgan B; Brouwer MC; van de Beek D
    J Thromb Haemost; 2015 Nov; 13(11):2076-86. PubMed ID: 26340319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?
    Antovic JP; Schulman S; An SS; Greenfield RS; Blombäck M
    Scand J Clin Lab Invest; 2004; 64(8):745-51. PubMed ID: 15719893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.
    Wu C; Kim PY; Manuel R; Seto M; Whitlow M; Nagashima M; Morser J; Gils A; Declerck P; Nesheim ME
    J Biol Chem; 2009 Mar; 284(11):7059-67. PubMed ID: 19074424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN; Meijers JC
    J Thromb Haemost; 2003 Jul; 1(7):1566-74. PubMed ID: 12871292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains.
    Hall SW; Nagashima M; Zhao L; Morser J; Leung LL
    J Biol Chem; 1999 Sep; 274(36):25510-6. PubMed ID: 10464282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice.
    Mao SS; Holahan MA; Bailey C; Wu G; Colussi D; Carroll SS; Cook JJ
    Blood Coagul Fibrinolysis; 2005 Sep; 16(6):407-15. PubMed ID: 16093731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a stable thrombin-activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation.
    Zhou X; Declerck PJ
    J Thromb Haemost; 2015 Jun; 13(6):1084-9. PubMed ID: 25773535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
    Nesheim M; Wang W; Boffa M; Nagashima M; Morser J; Bajzar L
    Thromb Haemost; 1997 Jul; 78(1):386-91. PubMed ID: 9198184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP; Blombäck M
    Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
    Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN; Marx PF; Mosnier LO; Meijers JC
    Thromb Res; 2001 Mar; 101(5):329-54. PubMed ID: 11297751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.